Oklahoma takes CVS Caremark to new PBM court
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback